Drugs / bOPV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03310073 | Jul 2016 → Mar 2017 | — | PT Bio Farma | Completed | No outcome recorded |
Press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2024-12-23 | PT Bio Farma | Kontribusi Pada Ketahanan Kesehatan Global : Bio Farma Sediakan 271,600 Vial Vaksin bOPV untuk Myanmar co.id ↗ |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | bOPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03310073 ↗ |
| Modality | Vaccine | “bivalent Oral Polio Vaccine” NCT03310073 ↗ |